688566 Stock Overview
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Jiangsu Jibeier Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥26.67 |
52 Week High | CN¥41.96 |
52 Week Low | CN¥17.49 |
Beta | 0.38 |
1 Month Change | 5.42% |
3 Month Change | 23.24% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -21.51% |
Recent News & Updates
Recent updates
Shareholder Returns
688566 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 6.1% | 5.6% | 3.1% |
1Y | n/a | -11.0% | -13.1% |
Return vs Industry: Insufficient data to determine how 688566 performed against the CN Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 688566 performed against the CN Market.
Price Volatility
688566 volatility | |
---|---|
688566 Average Weekly Movement | 8.8% |
Pharmaceuticals Industry Average Movement | 7.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688566's share price has been volatile over the past 3 months.
Volatility Over Time: 688566's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 970 | Zhongyi Geng | www.jbepharm.com |
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. The company’s products cover various therapeutic areas, such as improving white blood cells, anti-hypertension, enhancing immunity, treating joint diseases, anti-eye infection, treating bronchitis, protecting liver function, and other therapeutic fields. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases.
Jiangsu Jibeier Pharmaceutical Co., Ltd. Fundamentals Summary
688566 fundamental statistics | |
---|---|
Market cap | CN¥5.04b |
Earnings (TTM) | CN¥233.59m |
Revenue (TTM) | CN¥889.82m |
21.6x
P/E Ratio5.7x
P/S RatioIs 688566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688566 income statement (TTM) | |
---|---|
Revenue | CN¥889.82m |
Cost of Revenue | CN¥95.84m |
Gross Profit | CN¥793.98m |
Other Expenses | CN¥560.39m |
Earnings | CN¥233.59m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.24 |
Gross Margin | 89.23% |
Net Profit Margin | 26.25% |
Debt/Equity Ratio | 0.5% |
How did 688566 perform over the long term?
See historical performance and comparison